Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Monday, June 24, 2024.

Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Long-Term Downtrend (-90) - CNCR is in a strong downtrend that is likely to continue. While CNCR is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.

Is it time to buy, sell, or avoid CNCR?

MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

Open High Low CNCR Price Change
13.76 13.85 13.76 13.85 +0.13
Entry Signal

MarketClub’s Trade Triangles for CNCR

long term down The long-term trend has been DOWN since Jun 18th, 2024 at 13.77

intermediate term down The intermediate-term trend has been DOWN since Mar 18th, 2024 at 15.85

short term down The short-term trend has been DOWN since Jun 17th, 2024 at 14.47

Smart Scan Analysis for CNCR

Based on our trend formula, CNCR is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

Smart Scan Analysis for CNCR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
13.76 13.85 13.76 13.85 +0.13
Prev. Close Volume Bid Ask Time
13.87 806 2024-06-21 11:45:16
Year High32.32Year High Date2018-03-13
Year Low19.1252Year Low Date2018-10-29
52wk High17.959952wk High Date2024-03-01
52wk Low9.2252wk Low Date2023-10-27
Average Volume8,494Shares Outstanding100
Market Cap34MVolatility39.81
Get a free daily analysis and signals for Range Cancer Therapeutics ETF (CNCR) - Request Your Free Report.